Advertisement

Topics

Barrack, Rodos & Bacine Company Profile

08:14 EST 10th December 2018 | BioPortfolio


News Articles [1 Associated News Articles listed on BioPortfolio]

Stemgent: Fate, Obama and 74 new products

In this episode of PharmaVentures Business Review, Dr Fintan Walton caught up with Ian Ratcliffe, CEO of Stemgent, for an update on the company’s exciting past year. They discuss: • induced Pluri...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Cemented vs Cementless TKA

The purpose of this study is to compare cemented and cementless versions of the Triathlon total knee arthroplasty/replacement (TKA) in terms of clinical outcomes, perioperative course, and...

More Information about "Barrack, Rodos & Bacine" on BioPortfolio

We have published hundreds of Barrack, Rodos & Bacine news stories on BioPortfolio along with dozens of Barrack, Rodos & Bacine Clinical Trials and PubMed Articles about Barrack, Rodos & Bacine for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Barrack, Rodos & Bacine Companies in our database. You can also find out about relevant Barrack, Rodos & Bacine Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record